194 related articles for article (PubMed ID: 12860900)
21. 3-Hydroxy-3-methylglutaryl coenzyme A reductase in rainbow trout: effects of fasting and statin drugs on activities and mRNA transcripts.
Estey C; Chen X; Moon TW
Comp Biochem Physiol C Toxicol Pharmacol; 2008 Apr; 147(3):386-98. PubMed ID: 18280795
[TBL] [Abstract][Full Text] [Related]
22. Chlamydia pneumoniae stimulates proliferation of vascular smooth muscle cells through induction of endogenous heat shock protein 60.
Hirono S; Dibrov E; Hurtado C; Kostenuk A; Ducas R; Pierce GN
Circ Res; 2003 Oct; 93(8):710-6. PubMed ID: 14500333
[TBL] [Abstract][Full Text] [Related]
23. Simvastatin inhibits glucose-stimulated vascular smooth muscle cell migration involving increased expression of RhoB and a block of Ras/Akt signal.
Chan KC; Wu CH; Huang CN; Lan KP; Chang WC; Wang CJ
Cardiovasc Ther; 2012 Apr; 30(2):75-84. PubMed ID: 20946258
[TBL] [Abstract][Full Text] [Related]
24. Statins inhibit secretion of metalloproteinases-1, -2, -3, and -9 from vascular smooth muscle cells and macrophages.
Luan Z; Chase AJ; Newby AC
Arterioscler Thromb Vasc Biol; 2003 May; 23(5):769-75. PubMed ID: 12663370
[TBL] [Abstract][Full Text] [Related]
25. Dual regulation of tumor necrosis factor-alpha-induced CCL2/monocyte chemoattractant protein-1 expression in vascular smooth muscle cells by nuclear factor-kappaB and activator protein-1: modulation by type III phosphodiesterase inhibition.
Chen YM; Chiang WC; Lin SL; Wu KD; Tsai TJ; Hsieh BS
J Pharmacol Exp Ther; 2004 Jun; 309(3):978-86. PubMed ID: 14978197
[TBL] [Abstract][Full Text] [Related]
26. Cholestin (Monascus purpureus rice) inhibits homocysteine-induced reactive oxygen species generation, nuclear factor-kappaB activation, and vascular cell adhesion molecule-1 expression in human aortic endothelial cells.
Lin CP; Chen YH; Chen JW; Leu HB; Liu TZ; Liu PL; Huang SL
J Biomed Sci; 2008 Mar; 15(2):183-96. PubMed ID: 17906965
[TBL] [Abstract][Full Text] [Related]
27. Statins prevent pulsatile stretch-induced proliferation of human saphenous vein smooth muscle cells via inhibition of Rho/Rho-kinase pathway.
Kozai T; Eto M; Yang Z; Shimokawa H; Lüscher TF
Cardiovasc Res; 2005 Dec; 68(3):475-82. PubMed ID: 16098957
[TBL] [Abstract][Full Text] [Related]
28. Fluvastatin inhibits the expression of tumor necrosis factor-alpha and activation of nuclear factor-kappaB in human endothelial cells stimulated by C-reactive protein.
Wang HR; Li JJ; Huang CX; Jiang H
Clin Chim Acta; 2005 Mar; 353(1-2):53-60. PubMed ID: 15698590
[TBL] [Abstract][Full Text] [Related]
29. Statins reduce interleukin-6-induced C-reactive protein in human hepatocytes: new evidence for direct antiinflammatory effects of statins.
Arnaud C; Burger F; Steffens S; Veillard NR; Nguyen TH; Trono D; Mach F
Arterioscler Thromb Vasc Biol; 2005 Jun; 25(6):1231-6. PubMed ID: 15790934
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of geranylgeranylation reduces angiotensin II-mediated free radical production in vascular smooth muscle cells: involvement of angiotensin AT1 receptor expression and Rac1 GTPase.
Wassmann S; Laufs U; Bäumer AT; Müller K; Konkol C; Sauer H; Böhm M; Nickenig G
Mol Pharmacol; 2001 Mar; 59(3):646-54. PubMed ID: 11179461
[TBL] [Abstract][Full Text] [Related]
31. Direct anti-inflammatory mechanisms contribute to attenuation of experimental allograft arteriosclerosis by statins.
Shimizu K; Aikawa M; Takayama K; Libby P; Mitchell RN
Circulation; 2003 Oct; 108(17):2113-20. PubMed ID: 14517172
[TBL] [Abstract][Full Text] [Related]
32. Statins inhibit beta-adrenergic receptor-stimulated apoptosis in adult rat ventricular myocytes via a Rac1-dependent mechanism.
Ito M; Adachi T; Pimentel DR; Ido Y; Colucci WS
Circulation; 2004 Jul; 110(4):412-8. PubMed ID: 15262848
[TBL] [Abstract][Full Text] [Related]
33. Tissue factor induction by aggregated LDL depends on LDL receptor-related protein expression (LRP1) and Rho A translocation in human vascular smooth muscle cells.
Camino-López S; Llorente-Cortés V; Sendra J; Badimon L
Cardiovasc Res; 2007 Jan; 73(1):208-16. PubMed ID: 17141748
[TBL] [Abstract][Full Text] [Related]
34. Chlamydia pneumoniae induces a pro-inflammatory phenotype in murine vascular smooth muscle cells independently of elevating reactive oxygen species.
Rivera J; Walduck AK; Strugnell RA; Sobey CG; Drummond GR
Clin Exp Pharmacol Physiol; 2012 Mar; 39(3):218-26. PubMed ID: 22211630
[TBL] [Abstract][Full Text] [Related]
35. Regulation of monocyte chemoattractant protein-1 by the oxidized lipid, 13-hydroperoxyoctadecadienoic acid, in vascular smooth muscle cells via nuclear factor-kappa B (NF-kappa B).
Dwarakanath RS; Sahar S; Reddy MA; Castanotto D; Rossi JJ; Natarajan R
J Mol Cell Cardiol; 2004 Apr; 36(4):585-95. PubMed ID: 15081318
[TBL] [Abstract][Full Text] [Related]
36. FcgammaRIIa mediates C-reactive protein-induced inflammatory responses of human vascular smooth muscle cells by activating NADPH oxidase 4.
Ryu J; Lee CW; Shin JA; Park CS; Kim JJ; Park SJ; Han KH
Cardiovasc Res; 2007 Aug; 75(3):555-65. PubMed ID: 17531211
[TBL] [Abstract][Full Text] [Related]
37. A therapeutic dose of the lipophilic statin pitavastatin enhances oxidant-induced apoptosis in human vascular smooth muscle cells.
Tsujimoto A; Takemura G; Mikami A; Aoyama T; Ohno T; Maruyama R; Nakagawa M; Minatoguchi S; Fujiwara H
J Cardiovasc Pharmacol; 2006 Oct; 48(4):160-5. PubMed ID: 17086094
[TBL] [Abstract][Full Text] [Related]
38. HMG-CoA reductase inhibitors reduce adhesion of human monocytes to endothelial cells.
Teupser D; Bruegel M; Stein O; Stein Y; Thiery J
Biochem Biophys Res Commun; 2001 Dec; 289(4):838-44. PubMed ID: 11735122
[TBL] [Abstract][Full Text] [Related]
39. Hydroxymethylglutaryl--CoA reductase inhibitor inhibits induction of nitric oxide synthase in 3T3--L1 preadipocytes.
Dobashi K; Araki S; Kubo K; Kawagoe R; Yamamoto Y; Shirahata A
Life Sci; 2008 Jan; 82(1-2):85-90. PubMed ID: 18036617
[TBL] [Abstract][Full Text] [Related]
40. Hydroxymethylglutaryl-coenzyme A reductase inhibitors induce apoptosis in human cardiac myocytes in vitro.
Demyanets S; Kaun C; Pfaffenberger S; Hohensinner PJ; Rega G; Pammer J; Maurer G; Huber K; Wojta J
Biochem Pharmacol; 2006 Apr; 71(9):1324-30. PubMed ID: 16540096
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
